Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3034 |
|
| Actual shortage: | 241 (8%) | |
| Anticipated shortage: | 18 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-03-05 | 2019-03-09 | 77878 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-03-05 | 2019-03-09 | 77881 |
| APO-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-03-06 | 2019-03-09 | 77971 |
| APO-VALSARTAN | 160MG | TABLET | Resolved | 2017-03-11 | 2019-03-08 | 549 |
| APO-VALSARTAN | 80MG | TABLET | Resolved | 2017-03-10 | 2019-03-08 | 272 |
| APO PEN VK | 480000UNIT | POWDER FOR SOLUTION | Resolved | 2017-03-11 | 2019-03-08 | 432 |
| APO-VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-12-12 | 2019-03-08 | 69458 |
| APO-LEVOFLOXACIN | 500MG | TABLET | Resolved | 2019-02-24 | 2019-03-08 | 76723 |
| APO-ROSUVASTATIN | 5MG | TABLET | Resolved | 2019-02-13 | 2019-03-07 | 75629 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2019-02-06 | 2019-03-07 | 74932 |
| APO-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2019-02-13 | 2019-03-07 | 75620 |
| APO-ATORVASTATIN | 10MG | TABLET | Resolved | 2019-01-23 | 2019-03-07 | 73308 |
| APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Resolved | 2019-02-06 | 2019-03-01 | 74911 |
| APO-LAMOTRIGINE | 150MG | TABLET | Resolved | 2019-01-03 | 2019-03-01 | 71130 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2018-12-12 | 2019-02-26 | 69299 |
| APO-LEVOCARB-TAB 25MG/100MG | 25MG 100MG | TABLET | Resolved | 2019-02-06 | 2019-02-25 | 74896 |
| APO-LEVOCARB-TAB 25MG/100MG | 25MG 100MG | TABLET | Resolved | 2019-02-06 | 2019-02-25 | 74894 |
| BACKUP PLAN ONESTEP | 1.5MG | TABLET | Resolved | 2019-02-13 | 2019-02-21 | 75635 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-01-15 | 2019-02-21 | 72363 |
| APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2019-02-13 | 2019-02-21 | 75617 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-NORTRIPTYLINE | 10MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1145 |
| APO-NIZATIDINE | 300MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1135 |
| APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
| APO-METOCLOP TAB 5MG | 5mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1105 |
| APO-METOCLOP TAB 10MG | 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1101 |
| APO-LISINOPRIL/HCTZ | 25MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1096 |
| APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
| APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
| APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
| APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
| APO-DILTIAZ TZ | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1078 |
| APO-DILTIAZ TZ | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1075 |
| APO-DILTIAZ TZ | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1072 |
| APO-DILTIAZ TZ | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1069 |
| APO-DILTIAZ TZ | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1064 |
| APO PREDNISONE TAB 1MG USP | 1MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1056 |